Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Northwest Biotherapeutics (NWBO) recorded Depreciation & Amortization (CF) of $774,000 in Q2 2026, up 71.6% from $451,000 a year earlier and up 0.4% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, Northwest Biotherapeutics' Depreciation & Amortization (CF) came in at $2.72 million as of Jun 30, 2026, up 54.2% year-over-year; for FY2025, it came in at $2.06 million, up 18.3% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for six straight years, with a five-year compound annual growth rate of 88.4% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $1.74 million in FY2024 (+14.4%), $1.53 million in FY2023 (+21.8%), $1.25 million in FY2022 (+286.4%) and $324,000 in FY2021 (+272.4%).
  • The Q2 2026 figure is the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2010.
  • On a year-over-year basis, Depreciation & Amortization (CF) has increased for 12 consecutive quarters, with growth averaging 29.1% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 580.5% in Q2 2022, against a decline of 33.2% in Q2 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $771,000 (Q1 2026), $728,000 (Q4 2025) and $451,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 774,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 774,000.00
Mar 31, 2026 771,000.00
Dec 31, 2025 728,000.00
Sep 30, 2025 451,000.00
Jun 30, 2025 451,000.00
Mar 31, 2025 434,000.00
Dec 31, 2024 437,000.00
Sep 30, 2024 445,000.00
Jun 30, 2024 434,000.00
Mar 31, 2024 428,000.00
Dec 31, 2023 424,000.00
Sep 30, 2023 416,000.00
Jun 30, 2023 350,000.00
Mar 31, 2023 335,000.00
Dec 31, 2022 318,000.00
Sep 30, 2022 310,000.00
Jun 30, 2022 524,000.00
Mar 31, 2022 100,000.00
Dec 31, 2021 84,000.00
Sep 30, 2021 95,000.00
API Access

Northwest Biotherapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NWBO&period=max&api_key=YOUR_API_KEY